OPKO Health (OPK) Misses Q1 EPS by 1c, provides guidance

OPKO Health (NASDAQ: OPK) reported Q1 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $124.2 million versus the consensus estimate of $130.8 million.

GUIDANCE:

OPKO Health sees Q2 2026 revenue of $127-132 million, versus the consensus of $135.6 million.

OPKO Health sees FY2026 revenue of $530-560 million, versus the consensus of $545.6 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Varonis Systems (VRNS) call put ratio 4.4 calls to 1 put with a focus on July 35, 40 and 45 calls as share price up 6.4%